© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#blood cancer

Yescarta, CAR-T, axicabtagene ciloleucel
CAR-T Therapy: Lifeline to A Cure?
Imbruvica Bests Chemotherapy for Older People With Leukemia
Blood Cancers 101
Red and white blood cells

FDA Approves New Treatment for Chronic Lymphocytic Leukemia

This is the second therapy approved under a new program that lets companies simultaneously apply for approval in multiple countries.
Motoko Koyama, MD, PhD

Mystery Solved: How Graft-Versus-Host Disease Starts in the Gut

Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it

Blood Cancer Awareness Month

September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.

That’s a Lot of Cancer

September is the awareness period of a whopping total of seven cancers. Seven!

Scientists Take First Step Toward Using CRISPR to Cure HIV in Humans

Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.

September

I really have no idea how one should properly celebrate the month of one’s cancer.

Why Are Liver Disease Mortality Trends Shifting?

Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.

Multiple Myeloma

Cancer Health Focus

David Tracy received an experimental drug for BPDCN, a rare blood cancer, which is now part of standard therapy for the disease. The initial lesions on his back and chest are mostly gone or fading.

Researchers Making Headway on Treatment for Rare Blood Cancer

The trial is testing an experimental drug that targets one of the malignant immune cells that are a hallmark of the disease.
T cells attacking cancer cell

CAR T Cells Survive by Going Undercover

The researchers are now designing a first-in-human clinical trial to test the effectiveness of this approach in patients.

Cancer Awareness Months and Days

Shingles More Likely to Develop in People With Cancer

But new vaccines hold promise for prevention.
Damian Green, MD, presented the first results from his trial of genetically engineered immune cells for multiple myeloma. Green says this type of treatment could “dramatically alter the landscape in terms of how we manage multiple myeloma.”

‘Exciting’ but Early Results in Trial of Immunotherapy for Myeloma

Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease.

Study Aims to Cure Blood Cancers With Transplants That Could Block HIV, Too

Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
Connor McMahon (center), a 17-year-old three-time survivor of acute lymphblastic leukemia, on the “Good Morning America” set with co-host Michael Strahan (left) and New York Rangers goalie Henrik Lundqvist (right), McMahon’s favorite hockey player

Three-Time Cancer Survivor Is Helping Kids Like Him

After his first bout with acute lymphoblastic leukemia, Connor McMahon wanted to give other children hope.
Advertisement
Treatment News
Features